The US Mycoplasma Testing Market trajectory continues to point toward sustained expansion as the biopharmaceutical industry embraces advanced manufacturing and personalized medicine. With therapeutic modalities becoming increasingly cell-based and complex, the margin for contamination error continues to narrow. The ongoing development of closed, automated manufacturing systems is creating...